Joining mailing list will entitle you
to receive occasional emails informing you of news and
updates to the site and any special offers that may be
of interest to you.
NCI-Proteomics program aims to identify and characterize the protein signatures of human cells and tissues, and to apply technologies directly to patient diagnosis, monitoring and therapeutic intervention. Includes links to Frederick, Maryland.
Initiative to identify and measure proteins in biological systems, to accelerate discovery and translational projects. Includes overview of methods, potential therapies, symposia, workshops and news from Bethesda, Maryland.
Databases, methods, staff, publications, news and conferences from Ludwig Institute for Cancer Research and Walter and Eliza Hall Institute of Medical Research Melbourne, Australia.
Using functional proteomics, the primary focus of the lab is to understand the molecular signaling system that protects the heart against injury due to a lack of blood flow, or ischemia.
William Lane's lab at Harvard provides expertise and core technologies in proteomics for the Harvard community and researchers worldwide. These include mass spectrometry, high sensitivity peptide sequencing and protein identification, microcapillary and microbore HPLC separations of chemical or proteolytic digestions.
Facility for the research community, with instrumens, protocols, educational materials and message boards. Includes links to services and project feasibility submission at Michigan State University, East Lansing.
The Proteomics core facility has been founded in 2001 as a part of the Biocenter Oulu (BCO) at University of Oulu and comprises to 2-D gel electrophoresis, image analysis and protein identification by mass spectrometry.
Protocols and research into salmonid fish, rainbow trout liver proteins, their expression, biochemical pathways and degradation, using mass spectrometry and 2-dimensional electrophoresis.
Interaction Proteome is an integrated project to establish Europe as the international scientific leader in the analysis of protein-protein interactions.
PPI is working to define the research and regulatory agenda required to advance the exploration and diagnostic use of the human plasma proteome. Includes introduction to projects and participants' contacts in Washington DC.